Market revenue in 2023 | USD 232.7 million |
Market revenue in 2030 | USD 863.2 million |
Growth rate | 20.6% (CAGR from 2023 to 2030) |
Largest segment | Oligonucleotide synthesis |
Fastest growing segment | Gene Synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oligonucleotide Synthesis, Gene Synthesis |
Key market players worldwide | Thermo Fisher Scientific Inc, Twist Bioscience Corp, Codexis Inc, LGC Group, Eurofins Scientific SE, Genscript Biotech Corp Class H, Bioneer, IBA Lifesciences, Danaher Corp, Quintarabio |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna synthesis market will help companies and investors design strategic landscapes.
Oligonucleotide synthesis was the largest segment with a revenue share of 55.52% in 2023. Horizon Databook has segmented the China dna synthesis market based on oligonucleotide synthesis, gene synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
The growing demand for synthetic DNA in research & diagnostics, the increasing prevalence of genetic diseases, and the rising need for personalized medicine are some of the major factors fueling the demand for DNA-based therapies. Moreover, the growing investments and favorable government initiatives in the biotechnology sector in China are expected to boost the DNA synthesis market.
Moreover, expansion plays a key role in this market. It involves investing in larger and more advanced synthesis facilities. This increased production capacity allows companies to meet the growing demand for oligonucleotides and genomic pools, whether for research, diagnostics, or therapeutic applications.
For instance, in May 2023, GenScript Biotech Corporation expanded its primary manufacturing facility for oligonucleotide production in Jiangsu, China. In August 2023, Atantares raised an investment of USD 13.9 million in pre-Series A funding to support the development of molecular chips that can detect & synthesize DNA at lower costs.
Horizon Databook provides a detailed overview of country-level data and insights on the China dna synthesis market, including forecasts for subscribers. This country databook contains high-level insights into China dna synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account